In the modern medical landscape, Hydroxyapatite (HAp) has emerged as the gold standard for synthetic bone graft substitutes. As a primary mineral component of human bone and teeth, its bioactive properties allow for seamless integration with natural bone tissue. Globally, the bone substitute market is witnessing an unprecedented surge, driven by an aging population, the rise in orthopedic trauma cases, and advancements in dental implantology.
Currently, the industry is transitioning from simple filler materials to complex, osteoconductive and osteoinductive scaffolds. OEM/ODM Hydroxyapatite bone substitute factories are now focusing on high-purity synthetic HAp, which eliminates the risks of disease transmission associated with allografts and the donor-site morbidity of autografts. As a premier supplier, Guangzhou Clerivida Medical Co., Ltd. stands at the forefront of this evolution, utilizing nanostructured HAp to mimic the hierarchical structure of natural bone.
The shift towards patient-specific implants. OEM factories are now integrating HAp powders into 3D printing filaments to create customized scaffolds for complex craniofacial and orthopedic reconstructions.
Research is pivoting towards nano-HAp, which offers superior surface area for protein adsorption and cell attachment, significantly accelerating the healing process in osteoporotic patients.
Combining HAp with collagen or biodegradable polymers (like PLGA) to create hybrid substitutes that provide both mechanical strength and biological signaling.
Guangzhou Clerivida Medical Co., Ltd. is a leading manufacturer specializing in orthopedic implants and surgical instruments, offering a comprehensive model of research and development, production, sales, and export. The company has established a perfect quality management system and advanced production capabilities, ensuring every product meets international standards.
With over 18 years of dedicated research and development, Clerivida has developed 11 main product series, including spinal systems, intramedullary nail systems, trauma plates and screws, locking plates and screws, CMF maxillofacial systems, external fixation devices, joint replacement systems, medical power tools, general surgical instrument sets, sterilization boxes & baskets, and veterinary orthopedic solutions.
Global procurement needs for Hydroxyapatite Bone Substitutes are diverse. In North America and Europe, the demand is driven by the rise in spinal fusion surgeries and revision arthroplasty. Hospitals are seeking suppliers who can provide high-volume, sterile-packed HAp granules and blocks that meet stringent CE and FDA quality benchmarks. Meanwhile, in emerging markets across Southeast Asia and Latin America, the focus is on cost-effective, high-quality trauma solutions.
Localized Application Scenarios:
We leverage cutting-edge sintering technology and clean-room facilities that rival top-tier global manufacturers, ensuring the chemical purity of Ca10(PO4)6(OH)2 is maintained at >99%.
Unlike standard suppliers, we offer flexible OEM/ODM services. Whether you need specific porosity levels (interconnecting pores for vascularization) or custom-shaped blocks, our R&D team provides rapid prototyping.
Located in Guangzhou, we benefit from a robust logistics network and proximity to high-grade raw material sources, allowing us to offer competitive pricing without compromising on medical-grade quality.
Guided by the principle of "quality first, service first, R&D first, innovation first," the company has earned an excellent reputation both domestically and internationally. Customer satisfaction remains the cornerstone of Clerivida’s service philosophy, emphasizing sincere service, continuous improvement, attention to detail, and integrity.
With a professional after-sales team and a pioneering spirit, Clerivida continues to provide reliable, high-quality orthopedic solutions while building long-term partnerships with clients worldwide. The company remains committed to innovation, excellence, and advancing the orthopedic medical industry.